-1366x0.jpg)
This year’s conference will take place on Friday and Saturday, May 30–31, 2025, at Giao Te Hotel – No. 9 Ho Tung Mau Street, Hung Binh Ward, Vinh City, Nghe An Province.
As a sponsor accompanying this conference, GENTIS is honored to contribute in a small but meaningful way to this important event. The GENTIS booth at the event will showcase advanced testing methods in obstetrics and pediatrics, particularly highlighting three new PGT (Preimplantation Genetic Testing) packages: PGT-M 100+ for rare diseases, PGT NEXT, and PGT UPGRADE.
One outstanding feature of the PGT-M 100+ test at GENTIS is its ability to detect over 100 single-gene disorders with high accuracy. By using next-generation sequencing (NGS) technology combined with family-specific marker design, PGT-M 100+ can precisely detect even minor DNA variations—hidden factors that can lead to disease. This method allows for the identification of embryos that are free from disease-causing genes, thereby increasing the chance of having a healthy baby. In addition to using advanced technology, GENTIS’s PGT-M service includes comprehensive support from a team of experienced genetic counselors, assisting clients before, during, and after testing.
PGT NEXT is a preimplantation genetic screening method that detects aneuploidies across all 24 chromosomes and identifies structural abnormalities such as chromosomal deletions and duplications. This test can also detect embryos with polyploidy or haploidy—conditions often discarded due to suspected fertilization abnormalities (e.g., 0PN, 1PN, 2.1PN, 3PN). By analyzing the entire genome using NGS combined with SNP genotyping, PGT NEXT increases the accuracy of chromosomal abnormality detection and ensures the correct identification of genetic relationships among embryos within the same group, minimizing the risk of sample mix-ups due to human error.
PGT UPGRADE is an enhanced version of preimplantation genetic testing, capable of detecting not only aneuploidies across 24 chromosomes but also structural chromosomal abnormalities larger than 5 Mb. Notably, this test can identify embryos carrying balanced translocations—a genetic abnormality that may be inherited from a parent without showing symptoms but can impact the reproductive health of future generations. PGT UPGRADE provides in-depth and detailed genetic information, optimizing embryo selection before transfer, thereby improving the likelihood of successful pregnancy and healthy offspring.
In addition, GENTIS will also introduce three new tests at the Nghe An Obstetrics and Pediatrics Scientific Conference: GEN9, 77 Inherited Metabolic Disorders (77IMDs), and SLSS Biotinidase Deficiency Screening.
GEN9 is a pre-marital/pre-pregnancy genetic screening test that screens for 9 recessive single-gene disorders such as Alpha-thalassemia, Beta-thalassemia, G6PD deficiency, phenylketonuria, galactose metabolism disorder, citrin deficiency-related cholestatic jaundice, Pompe disease, Wilson disease, 5-alpha-reductase type 2 deficiency, and Fabry disease. GEN9 helps assess the risk of passing genetic conditions to offspring if both parents are carriers, allowing for timely reproductive planning and support to eliminate disease-causing genes.
The 77IMDs test and SLSS Biotinidase Deficiency Screening are two essential newborn screening methods to detect congenital disorders early. The 77IMDs test screens for over 70 metabolic disorders, including issues with amino acid, fatty acid, and organic acid metabolism. Meanwhile, SLSS Biotinidase Deficiency Screening detects a deficiency in the biotinidase enzyme, crucial for biotin metabolism. These tests are vital in identifying conditions that may not present symptoms at birth. Early diagnosis allows for timely medical intervention, reducing the risk of severe complications and improving the quality of life for newborns.
Let’s welcome the 2nd Expanded Obstetrics and Pediatrics Scientific Conference of Nghe An, a significant event marking progress and success in Vietnam’s healthcare sector!
We look forward to welcoming distinguished delegates at the GENTIS booth!
